FR2320107B1 - - Google Patents

Info

Publication number
FR2320107B1
FR2320107B1 FR7524440A FR7524440A FR2320107B1 FR 2320107 B1 FR2320107 B1 FR 2320107B1 FR 7524440 A FR7524440 A FR 7524440A FR 7524440 A FR7524440 A FR 7524440A FR 2320107 B1 FR2320107 B1 FR 2320107B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7524440A
Other languages
French (fr)
Other versions
FR2320107A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Priority to FR7524440A priority Critical patent/FR2320107A1/fr
Priority to BE169371A priority patent/BE844672A/xx
Priority to SE7608640A priority patent/SE7608640L/xx
Priority to GB32081/76A priority patent/GB1525763A/en
Priority to IL50187A priority patent/IL50187A0/xx
Priority to US05/711,193 priority patent/US4110434A/en
Priority to DE19762634904 priority patent/DE2634904A1/de
Priority to LU75522A priority patent/LU75522A1/xx
Priority to NL7608680A priority patent/NL7608680A/xx
Priority to JP51093095A priority patent/JPS5234917A/ja
Priority to DK352276A priority patent/DK352276A/da
Publication of FR2320107A1 publication Critical patent/FR2320107A1/fr
Application granted granted Critical
Publication of FR2320107B1 publication Critical patent/FR2320107B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/5555Muramyl dipeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55583Polysaccharides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/32Mycobacterium
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/27Cyclic peptide or cyclic protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
FR7524440A 1975-08-05 1975-08-05 Nouveaux adjuvants immunologiques, procede pour leur obtention et compositions les contenant Granted FR2320107A1 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR7524440A FR2320107A1 (fr) 1975-08-05 1975-08-05 Nouveaux adjuvants immunologiques, procede pour leur obtention et compositions les contenant
BE169371A BE844672A (fr) 1975-08-05 1976-07-29 Nouveaux immonologiques, procede pour leur obtention et compositions les contenant
SE7608640A SE7608640L (sv) 1975-08-05 1976-07-30 Nya immunologiska adjuvantia, forfarande for framtellning derav samt kompositioner innehallande desamma
IL50187A IL50187A0 (en) 1975-08-05 1976-08-02 Novel immunological adjuvants their production and compositions containing them
GB32081/76A GB1525763A (en) 1975-08-05 1976-08-02 Immunological adjuvants process for their production and compositions containing them
DE19762634904 DE2634904A1 (de) 1975-08-05 1976-08-03 Neue immunologische adjuvantien, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
US05/711,193 US4110434A (en) 1975-08-05 1976-08-03 Novel immunological adjuvants, process for their production and compositions containing them
LU75522A LU75522A1 (US20110009641A1-20110113-C00185.png) 1975-08-05 1976-08-03
NL7608680A NL7608680A (nl) 1975-08-05 1976-08-04 Werkwijze voor het bereiden van nieuwe immunologische ondersteuningsmiddelen.
JP51093095A JPS5234917A (en) 1975-08-05 1976-08-04 Novel immunological medicine * production thereof and composition containing same
DK352276A DK352276A (da) 1975-08-05 1976-08-04 Immunologiske adjuvanser og fremgangsmade til fremstilling deraf

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7524440A FR2320107A1 (fr) 1975-08-05 1975-08-05 Nouveaux adjuvants immunologiques, procede pour leur obtention et compositions les contenant

Publications (2)

Publication Number Publication Date
FR2320107A1 FR2320107A1 (fr) 1977-03-04
FR2320107B1 true FR2320107B1 (US20110009641A1-20110113-C00185.png) 1980-01-11

Family

ID=9158793

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7524440A Granted FR2320107A1 (fr) 1975-08-05 1975-08-05 Nouveaux adjuvants immunologiques, procede pour leur obtention et compositions les contenant

Country Status (11)

Country Link
US (1) US4110434A (US20110009641A1-20110113-C00185.png)
JP (1) JPS5234917A (US20110009641A1-20110113-C00185.png)
BE (1) BE844672A (US20110009641A1-20110113-C00185.png)
DE (1) DE2634904A1 (US20110009641A1-20110113-C00185.png)
DK (1) DK352276A (US20110009641A1-20110113-C00185.png)
FR (1) FR2320107A1 (US20110009641A1-20110113-C00185.png)
GB (1) GB1525763A (US20110009641A1-20110113-C00185.png)
IL (1) IL50187A0 (US20110009641A1-20110113-C00185.png)
LU (1) LU75522A1 (US20110009641A1-20110113-C00185.png)
NL (1) NL7608680A (US20110009641A1-20110113-C00185.png)
SE (1) SE7608640L (US20110009641A1-20110113-C00185.png)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU727647A1 (ru) * 1977-11-02 1980-04-15 Институт биоорганической химии им.М.М.Шемякина Гликопептиды,обладающие противоопухолевой активностью и способ их получени
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
US4313934A (en) * 1979-05-08 1982-02-02 Kirin Beer Kabushiki Kaisha Physiologically active polysaccharides, production and uses thereof
JPS59116681A (ja) * 1982-12-23 1984-07-05 セイコーインスツルメンツ株式会社 液晶表示装置
US4897256A (en) * 1986-11-25 1990-01-30 Abbott Laboratories LHRH analog formulations
JPH08508976A (ja) * 1993-01-29 1996-09-24 ベトレフアーム・インコーポレーテツド 改善化免疫療法用組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL2816C (US20110009641A1-20110113-C00185.png) *
US3429868A (en) * 1956-03-12 1969-02-25 Kiyoshi Kominato Method of preparing a series of prosthetic groups and coenzymes of a new redox-enzyme which are present in plants,animals,or foods and have vitamin-like activity
NL7308450A (US20110009641A1-20110113-C00185.png) * 1972-06-20 1973-12-27
US3941762A (en) * 1973-05-07 1976-03-02 E. R. Squibb & Sons, Inc. O-acyl derivatives of antibiotic EM-49
FR2269961B1 (US20110009641A1-20110113-C00185.png) * 1974-05-06 1978-03-24 Anvar
US3992528A (en) * 1975-02-18 1976-11-16 Research Corporation Anti-viral substance containing peptide, fatty acid and carbohydrate moieties

Also Published As

Publication number Publication date
DE2634904A1 (de) 1977-02-10
DK352276A (da) 1977-02-06
IL50187A0 (en) 1976-10-31
LU75522A1 (US20110009641A1-20110113-C00185.png) 1977-03-25
US4110434A (en) 1978-08-29
FR2320107A1 (fr) 1977-03-04
JPS5234917A (en) 1977-03-17
GB1525763A (en) 1978-09-20
NL7608680A (nl) 1977-02-08
BE844672A (fr) 1976-11-16
SE7608640L (sv) 1977-02-06

Similar Documents

Publication Publication Date Title
FR2297074B1 (US20110009641A1-20110113-C00185.png)
FR2322182B1 (US20110009641A1-20110113-C00185.png)
FR2320107B1 (US20110009641A1-20110113-C00185.png)
JPS51124401U (US20110009641A1-20110113-C00185.png)
JPS5515896Y2 (US20110009641A1-20110113-C00185.png)
JPS5338514B2 (US20110009641A1-20110113-C00185.png)
JPS5190679U (US20110009641A1-20110113-C00185.png)
JPS51106484U (US20110009641A1-20110113-C00185.png)
JPS528968U (US20110009641A1-20110113-C00185.png)
JPS5244472U (US20110009641A1-20110113-C00185.png)
JPS5247277U (US20110009641A1-20110113-C00185.png)
JPS5614276Y2 (US20110009641A1-20110113-C00185.png)
JPS547661B2 (US20110009641A1-20110113-C00185.png)
JPS51110826A (US20110009641A1-20110113-C00185.png)
JPS5271011U (US20110009641A1-20110113-C00185.png)
JPS5275083U (US20110009641A1-20110113-C00185.png)
JPS5250804U (US20110009641A1-20110113-C00185.png)
JPS51157610U (US20110009641A1-20110113-C00185.png)
JPS51106331U (US20110009641A1-20110113-C00185.png)
CH600555A5 (US20110009641A1-20110113-C00185.png)
CH602979A5 (US20110009641A1-20110113-C00185.png)
CH598055A5 (US20110009641A1-20110113-C00185.png)
CH598286A5 (US20110009641A1-20110113-C00185.png)
CH598941A5 (US20110009641A1-20110113-C00185.png)
CH597994A5 (US20110009641A1-20110113-C00185.png)

Legal Events

Date Code Title Description
ST Notification of lapse